Cytokines in RVO: Exploring New Horizons
ADITYA MODI, MBBS, DNB, FVRS • P. NEHA SUDHAKAR, MBBS, MS • NARESH KUMAR YADAV, MBBS, DOMS, FMRF, FRCS (GLAS)
A scientific overview and possible treatment paradigm
Treatment of Retinal Vein Occlusion
HUSSEIN ALMUHTASEB, MD, MSC, FEBO • ANDREW LOTERY, MD, FRCOphth
The first of two parts
The Affordable Care Act’s Next Step
The Medicare 60-day overpayment rule is now final. What does it mean for retinal physicians?
Retinoblastoma Treatment in 2016: Changes in the 20th Century Paradigm
DAVID H. ABRAMSON, MD, FACS
The new century has brought new treatment protocols.
Pharmacologic Vitreolysis for Retinal Disease
DEREK KUNIMOTO, MD, JD
New options for separating the vitreous from the retina have the potential to improve care in several conditions.
Peter K. Kaiser, MD
Grab a Glass of Wine
BY JERRY HELZNER, CONTRIBUTING EDITOR
Innovation in Retina
JERRY HELZNER, CONTRIBUTING EDITOR
Dr. Gregory Hageman and the Role of Complement in AMD
SUZANNE L. CORCORAN, COE
Diagnostic Tests Receiving Greater Scrutiny — Are Yours up to Snuff?
NEW PRODUCT APPLICATIONS
BY KAREN APPOLD, CONTRIBUTING WRITER
A Single-use Wide-angle Viewing System